key: cord-0997636-v7jkyetz authors: Pfefferle, S.; Guenther, T.; Kobbe, R.; Czech-Sioli, M.; Noerz, D.; Santer, R.; Oh, J.; Kluge, S.; Oestereich, L.; Peldschus, K.; Indenbirken, D.; Huang, J.; Grundhoff, A.; Aepfelbacher, M.; Knobloch, J.; luetgehetmann, M.; Fischer, N. title: Low and high infection dose transmission of SARS-CoV-2 in the first COVID-19 clusters in Northern Germany date: 2020-06-16 journal: nan DOI: 10.1101/2020.06.11.20127332 sha: 3b0007032207da7e2af69261ddd6cff5743abe14 doc_id: 997636 cord_uid: v7jkyetz Objectives: We used viral genomics to deeply analyze the first SARS-CoV-2 infection clusters in the metropolitan region of Hamburg, Germany. Epidemiological analysis and contact tracing together with a thorough investigation of virus variant patterns revealed low and high infection dose transmissions to be involved in transmission events. Methods: Infection control measures were applied to follow up contract tracing. Metagenomic RNA- and SARS-CoV-2 amplicon sequencing was performed from 25 clinical samples for sequence analysis and variant calling. Results: The index patient acquired SARS-CoV-2 in Italy and after his return to Hamburg transmitted it to 2 out of 132 contacts. Virus genomics and variant pattern clearly confirms the initial local cluster. We identify frequent single nucleotide polymorphisms at positions 241, 3037, 14408, 23403 and 28881 previously described in Italian sequences and now considered as one major genotype in Europe. While the index patient showed a single nucleotide polymorphism only one variant was transmitted to the recipients. Different to the initial cluster, we observed in household clusters occurring at the time in Hamburg also intra-host viral species transmission events. Conclusions: SARS-CoV-2 variant tracing highlights both, low infection dose transmissions suggestive of fomites as route of infection in the initial cluster and high and low infection dose transmissions in family clusters indicative of fomites and droplets as infection routes. This suggests (1) single viral particle infection can be sufficient to initiate SARS-CoV-2 infection and (2) household/family members are exposed to high virus loads and therefore have a high risk to acquire SARS-CoV-2. SARS-CoV-2, first emerged in late 2019 as the alleged cause of a cluster of viral pneumonia cases in 57 Wuhan (1). The virus and its associated disease, COVID-19 have since given rise to a worldwide 58 pandemic. Significant findings addressing epidemiology, containment measures, transmission dynamics 59 and course of the disease have been published worldwide in short intervals. However, questions with 60 regard to the infectivity of the virus, how many viral particles are sufficient for infection, are droplets 61 or fomites the predominant transmission routes, still need to be addressed in more detail. 62 Viral sequence data were immediately publically available and online tools such as GISAID provided 63 graphical interfaces for phylogenetic network analyses (1-6). Viral genomics can further be used to 64 deepen our understanding of infection routes and viral sequence variability, which might be contributing 65 to the clinical course of the disease. 66 Previous reports suggest frequent human-to-human transmission together with a wide range of clinical 67 severity, including patients showing mild or no symptoms with at the same time high concentrations of 68 viral RNA detectable in respiratory samples (7-9). 69 Interestingly, a recent report describes the dynamics of viral shedding and transmissibility of SARS-70 CoV-2 with more than 44% of transmission occurring prior to symptom onset and viral loads peaking 71 before or at the time of symptom onset (10). This implies that not only health care workers need adequate 72 protection due to more frequent contact with infected patients (with high viral load) but especially 73 household/family members are at high risk due to high exposure and close contact. 74 While the viral load effect on incidence of infection and severity of the disease is currently discussed, 75 however, infecting dose measurements are highly challenging and can only be adequately addressed in 76 animal models. Personnel with high-risk contacts were sent to home quarantine for 14 days and were tested at the end 111 of their quarantine. Employees with low risk contacts remained on duty and voluntary testing was 112 provided on day 7 after the last contact to the index patient. independent detection parameters to generate frequency-based calls for all variants passing input 157 thresholds (-K -F 0.01). Input thresholds were set to 10 variant supporting reads with a minimum base 158 quality of 30 (-C10 -q30). Only high confidence variants present in > 33% of reads within at least one 159 individual sample were included and annotated using ANNOVAR (22).Variants located in non-coding 160 regions or representing frameshift, stopgain or startloss were deleted. Data were clustered by hclust 161 clustering method ward.D2. 162 To detect subgenomic mRNAs reads containing 10 upstream bases and the 6 core element bases of the 163 transcription-regulating sequence (TRS-L) fused to the 10 bases following the TRSs of the subgenomic 164 mRNA bodies (TRS-B) of the individual subgenomic mRNAs were counted. 165 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. In February 2020 a physician (index patient) returned from Trentino, Italy, at this time, not defined as a 172 risk area for contracting SARS-CoV-2 (23). 2 days after his return, he developed symptoms of a cold, 173 stopped his duty and stayed in home quarantine together with a relative thereafter. He was laboratory 174 confirmed as SARS-CoV-2 positive (Figure 1 ). 175 During these 2 days patient 0 had contact with 131 persons at the workplace. Out of these, 33 were high 176 risk (category I) and 98 were low risk contacts (category II). These contacts and a relative of patient 0 177 were tested negative on February 28th. One high risk workplace contact (patient 1) who had two contacts 178 with Patient 0 developed symptoms 3d later and was subsequently tested positive. Similarly, a relative 179 of patient 0 (patient 2) was tested positive for SARS-CoV-2 at that time. All other high risk contacts, 180 retested at day 7 (n=17) and/or at day 14 (n=28) after the last contact with patient 0 stayed SARS-CoV-181 2 negative. 40 low risk contacts were tested negative at day 7 after the last contact with patient 0. (Table S3) . 191 Interestingly, from an oropharyngeal swab of patient 2, who stayed asymptomatic, infectious SARS-192 CoV-2 could be successfully propagated in cell culture (24) suggestive of active viral replication. This 193 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 16, 2020. . https://doi.org/10.1101/2020.06.11.20127332 doi: medRxiv preprint is furthermore supported by our data obtained from RNA shotgun sequencing, in which we detect reads 194 spanning the SARS-CoV-2 leader sequence and regions of subgenomic RNAs (sgRNAs) ( Table 1) . 195 All three patients seroconverted ( Figure 1 , Table S3 ), within 10-14 d after the first positive PCR report. 196 Since we did not obtain high virus coverage by shotgun sequencing over the complete SARS-CoV-2 199 genome in all samples, we performed SARS-CoV-2 amplicon sequencing. This allowed us to thoroughly 200 characterize viral genomes, confirm the relationship of the viral sequences and identify possible 201 sequence variants. We obtained coverage of more than 98% of all SARS-CoV-2 genomes included 202 (n=25) with 23 samples showing >99.5% coverage, the maximum coverage of amplicon sequencing, 203 due to primer positioning at the very 5' and 3' ends. We identified 37 sequence variants, with 26 variants 204 not used for clade or genotype assignment and 9 variants not represented in the GISAID database ( Figure 205 2). Overall, mutations within the nucleotide sequence were relatively rare. We find between 2 to 12 206 consensus level variants per sample and only few, 1-2, sub-consensus variants occurring in 30% of the 207 samples. Based on the observed SNPs we can clearly cluster the sequences in distinct variant patterns, 208 pattern I, II (II.1-II.4) and III ( Figure 2 ). The clustering is driven by the presence of few SNPs, frequently 209 found in SARS-CoV-2 sequences. These were described e.g. in the leader sequence, position 241 co-210 occurring with mutations within the nsp3 (nt 3037), RNApol (nt 14408) and spike protein (nt 23403). 211 These co-occurring mutations have been recently described as one major SARS-CoV-2 variant 212 occurring in Europe and suggested to be defined as genotype II (6). The earliest representative of this 213 prevalent SNP pattern in GISAID (3, 25) is in an Italian sequence (Italy/CDG1/2020/412973) entered 214 on February 20 th . We identified these mutations in one cluster of related infections from persons 215 returning from a weekend of clubbing in Berlin (Figure 2 , pattern II.1). In addition to these 4 core 216 variants additional frequent variants are known and here described as sub-clusters of cluster II. Cluster 217 II.2 is defined by an additional frequent mutation of three consecutive bases in the nucleocapsid 218 phosphoprotein, nt 28,881 resulting in two aa changes. This SNP is described in approximately 25% of 219 sequences in GISAID with its first description on February 24 th , Netherlands/Berlicum_1363564/2020. 220 Sequences isolated from our index patient, patient 1 and 2 are clustering in pattern II.2. The sequences 221 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 16, 2020. . https://doi.org/10.1101/2020.06.11.20127332 doi: medRxiv preprint are highly related defined by an additional SNP at position 160, a variant not described in any sequence 222 currently deposited in any database (3, 25). Thus, the mutation at position 160 in combination with the 223 anamnestic data and the chronological development of test positivity in the three patients, proves that 224 patient 1 and -2 acquired SARS-CoV-2 from patient 0. 225 Interestingly, we identify a unique mutation acquired in patient 1, nt 2393 within orf1ab resulting in an 226 aa substitution Val to Phe at position 710 in the non-structural protein nsp2 ( Table 2) . The nsp2 protein 227 shows relatively little conservation across coronaviruses and is dispensable for replication in vitro (26). 228 However, recent reports suggest that nsp2 can modulate the host cell environment, including 229 transcriptional processes (27). (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 16, 2020. We performed unbiased metagenomic RNA sequencing from respiratory specimens of the 25 patients 271 included to detect putative viral and bacterial co-infections (Tables 3, S4-S6) . While we did not observe significant overrepresentation of sequences indicative of bacterial co-277 infections in the patients 0 or 2, an early throat swap sample from patient 1 exhibited a high proportion 278 of sequences assigned to Moraxella catharralis and Staphylococcus aureus (24.56% and 19.55% 279 relative abundance, respectively). However, tracheal secretion and BAL fluid from patient 1 at later time 280 points (under ICU treatment) did not find evidence for persistent bacterial co-infection with Moraxella 281 catharrhalis or any other pathogen known as a cause for respiratory infection (Table 3) . Although we detected mutations between different patient's samples the overall frequency was relatively 296 low. Our observation is different to a recent report in which high frequency of SARS-CoV-2 mutations 297 was described (28). Differences can be explained by the relatively conservative variant calling approach 298 in our analysis with variant frequency >33% being reported compared to 5% variant frequency as cut-299 off in the recently published report. Similar to previous reports, we did not find any mutation hot-spot 300 genes in our analysis. 301 Within the initial cluster (patient 0, 1 and 2), we identify a single non-synonymous mutation gained in 302 the prevalent virus sequence recovered from patient 1. This mutation has not been described before and 303 results in an aa substitution at position 710 of the non-structural protein nsp2. While we have no 304 indication that this aa substitution has functional consequences for viral replication or host interaction, 305 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 16, 2020. . https://doi.org/10.1101/2020.06.11.20127332 doi: medRxiv preprint it is interesting that nsp2 is dispensable in vitro and not very well conserved between coronaviruses. 306 Interestingly, mutations within nsp2 have been described (26, 29, 30) suggesting a more stable nsp2 307 protein and thereby contributing to higher pathogenicity (29). 308 Second, to our knowledge we describe the first report of intra-host variant transmissions of SARS-CoV- (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 16, 2020. . https://doi.org/10.1101/2020.06.11.20127332 doi: medRxiv preprint We declare no competing of interest. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 16, 2020. . https://doi.org/10.1101/2020.06.11.20127332 doi: medRxiv preprint respectively. Initial occurrence of symptoms is indicated by an arrow. ICU treatment of patient 1 is 415 labelled with a yellow rectangle. The dashed lines indicate threshold for reporting positive results of the 416 ELISA (= signal to noise ratio, s/n >1). 417 (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 16, 2020. . https://doi.org/10.1101/2020.06.11.20127332 doi: medRxiv preprint culture 340 24 6 10 13 24 18 8 87 190 total c 389 30 20 28 23 25 36 11 264 Summary of subgenomic mRNA-detecting reads spanning the leader sequence fused to the genome region 446 encoding for structural and accessory proteins. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 16, 2020. . https://doi.org/10.1101/2020.06.11.20127332 doi: medRxiv preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 16, 2020. . https://doi.org/10.1101/2020.06.11.20127332 doi: medRxiv preprint A Novel Coronavirus from Patients 340 with Pneumonia in China Phylogenetic network analysis of SARS-CoV-2 342 genomes Global initiative on sharing all influenza data -from vision to 344 reality On the origin and continuing evolution of 346 SARS-CoV-2. National Science Review Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions Genotyping coronavirus SARS-CoV-2: methods and implications of Novel Coronavirus-Infected Pneumonia SARS-CoV-2 Viral Load in Upper 354 Respiratory Specimens of Infected Patients Clinical Characteristics of Coronavirus 356 Disease 2019 in China Temporal dynamics in viral shedding 358 and transmissibility of COVID-19 for the detection of the emerging coronavirus SARS-CoV-2 using a high throughput system Virological 363 assessment of hospitalized cases of coronavirus disease 2019 Reverse genetic 365 characterization of the natural genomic deletion in SARS-Coronavirus strain Frankfurt-1 open reading 366 frame 7b reveals an attenuating function of the 7b protein in-vitro and in-vivo coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors DAMIAN: 371 an open source bioinformatics tool for fast, systematic and cohort based analysis of microorganisms in 372 diagnostic samples Unbiased Next-Generation Sequencing of RNA (RNA-seq) as a Diagnostic Method in Influenza Virus-375 Positive Respiratory Samples Rapid 377 metagenomic diagnostics for suspected outbreak of severe pneumonia Recovery of the first 380 full-length genome sequence of a parapoxvirus directly from a clinical sample PEAR: a fast and accurate Illumina Paired-End reAd 382 mergeR Minimap2: pairwise alignment for nucleotide sequences Haplotype-based variant detection from short-read sequencing